aluates Reports

$ 0.0

Automative

Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Research Report 2025

Published Date: 2025-07-07

Report Code: QYRE-Auto-12E5844

Global ALK Tyrosine Kinase Inhibitors ALK TKIs Market Insights Forecast to 2028

BUY CHAPTERS

Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Research Report 2025

Code: QYRE-Auto-12E5844

Report

2025-07-07

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Chugai Pharmaceutical Co

ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market

The global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Anaplastic Lymphoma Kinase (ALK) gene, as a tyrosine kinase closely related to tumors, can be activated by translocation or mutation. Abnormal expression such as gene mutation, rearrangement and amplification can activate cell signal transduction in the body. Pathway, which regulates the growth, differentiation and migration of tumors. Tyrosine kinases are kinases that enzymatically catalyze the transfer of gamma phosphate groups from adenosine triphosphate to target proteins. They can catalyze the phosphorylation of protein tyrosine residues on a variety of substrates, and play an important role in cell growth, proliferation, and differentiation. The main oncology indications for tyrosine kinase inhibitors (TKI) include solid tumors and leukemia.

North American market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs) in Leukemia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) include Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding, Chugai Pharmaceutical Co, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for ALK Tyrosine Kinase Inhibitors (ALK-TKIs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ALK Tyrosine Kinase Inhibitors (ALK-TKIs).

The ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Report

Report Metric	Details
Report Name	ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market
Segment by Type	Crizotinib Alectinib Ceritinib Brigatinib Lorlatinib Ensartinib CT-707
Segment by Application	Leukemia Solid Tumor Lung Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding, Chugai Pharmaceutical Co
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market report?

Ans: The main players in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market are Pfizer, Nuvartis, Takeda, Betta Pharma, Shouyao Holding, Chugai Pharmaceutical Co

What are the Application segmentation covered in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market report?

Ans: The Applications covered in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market report are Leukemia, Solid Tumor, Lung Cancer, Others

What are the Type segmentation covered in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market report?

Ans: The Types covered in the ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market report are Crizotinib, Alectinib, Ceritinib, Brigatinib, Lorlatinib, Ensartinib, CT-707

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Crizotinib

1.2.3 Alectinib

1.2.4 Ceritinib

1.2.5 Brigatinib

1.2.6 Lorlatinib

1.2.7 Ensartinib

1.2.8 CT-707

1.3 Market by Application

1.3.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Leukemia

1.3.3 Solid Tumor

1.3.4 Lung Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Perspective (2020-2031)

2.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Growth Trends by Region

2.2.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Region (2020-2025)

2.2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Region (2026-2031)

2.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Dynamics

2.3.1 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Industry Trends

2.3.2 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Drivers

2.3.3 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Challenges

2.3.4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Revenue

3.1.1 Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Revenue (2020-2025)

3.1.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Players (2020-2025)

3.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue

3.4 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Concentration Ratio

3.4.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in 2024

3.5 Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Head office and Area Served

3.6 Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs), Product and Application

3.7 Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Breakdown Data by Type

4.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Type (2020-2025)

4.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Type (2026-2031)

5 ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Breakdown Data by Application

5.1 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Historic Market Size by Application (2020-2025)

5.2 Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2020-2031)

6.2 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025)

6.4 North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2020-2031)

7.2 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025)

7.4 Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2020-2031)

8.2 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2020-2025)

8.4 Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2020-2031)

9.2 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025)

9.4 Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (2020-2031)

10.2 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025)

10.4 Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.1.4 Pfizer Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Nuvartis

11.2.1 Nuvartis Company Details

11.2.2 Nuvartis Business Overview

11.2.3 Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.2.4 Nuvartis Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.2.5 Nuvartis Recent Development

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.3.4 Takeda Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.3.5 Takeda Recent Development

11.4 Betta Pharma

11.4.1 Betta Pharma Company Details

11.4.2 Betta Pharma Business Overview

11.4.3 Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.4.4 Betta Pharma Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.4.5 Betta Pharma Recent Development

11.5 Shouyao Holding

11.5.1 Shouyao Holding Company Details

11.5.2 Shouyao Holding Business Overview

11.5.3 Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.5.4 Shouyao Holding Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.5.5 Shouyao Holding Recent Development

11.6 Chugai Pharmaceutical Co

11.6.1 Chugai Pharmaceutical Co Company Details

11.6.2 Chugai Pharmaceutical Co Business Overview

11.6.3 Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Introduction

11.6.4 Chugai Pharmaceutical Co Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

11.6.5 Chugai Pharmaceutical Co Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Chugai Pharmaceutical Co

List of Tables

Table 1. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Crizotinib

Table 3. Key Players of Alectinib

Table 4. Key Players of Ceritinib

Table 5. Key Players of Brigatinib

Table 6. Key Players of Lorlatinib

Table 7. Key Players of Ensartinib

Table 8. Key Players of CT-707

Table 9. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2020-2025)

Table 13. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2026-2031)

Table 15. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Trends

Table 16. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Drivers

Table 17. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Challenges

Table 18. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Restraints

Table 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Players (2020-2025)

Table 21. Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) as of 2024)

Table 22. Ranking of Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs), Headquarters and Area Served

Table 25. Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs), Product and Application

Table 26. Global Key Players of ALK Tyrosine Kinase Inhibitors (ALK-TKIs), Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Type (2020-2025)

Table 30. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Type (2026-2031)

Table 32. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Application (2020-2025)

Table 34. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue Market Share by Application (2026-2031)

Table 36. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Country (2026-2031) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 54. Pfizer Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Nuvartis Company Details

Table 57. Nuvartis Business Overview

Table 58. Nuvartis ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 59. Nuvartis Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 60. Nuvartis Recent Development

Table 61. Takeda Company Details

Table 62. Takeda Business Overview

Table 63. Takeda ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 64. Takeda Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 65. Takeda Recent Development

Table 66. Betta Pharma Company Details

Table 67. Betta Pharma Business Overview

Table 68. Betta Pharma ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 69. Betta Pharma Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 70. Betta Pharma Recent Development

Table 71. Shouyao Holding Company Details

Table 72. Shouyao Holding Business Overview

Table 73. Shouyao Holding ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 74. Shouyao Holding Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 75. Shouyao Holding Recent Development

Table 76. Chugai Pharmaceutical Co Company Details

Table 77. Chugai Pharmaceutical Co Business Overview

Table 78. Chugai Pharmaceutical Co ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Product

Table 79. Chugai Pharmaceutical Co Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025) & (US$ Million)

Table 80. Chugai Pharmaceutical Co Recent Development

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

Table 84. Authors List of This Report

List of Figures

Figure 1. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Picture

Figure 2. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Type: 2024 VS 2031

Figure 4. Crizotinib Features

Figure 5. Alectinib Features

Figure 6. Ceritinib Features

Figure 7. Brigatinib Features

Figure 8. Lorlatinib Features

Figure 9. Ensartinib Features

Figure 10. CT-707 Features

Figure 11. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Application: 2024 VS 2031

Figure 13. Leukemia Case Studies

Figure 14. Solid Tumor Case Studies

Figure 15. Lung Cancer Case Studies

Figure 16. Others Case Studies

Figure 17. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Report Years Considered

Figure 18. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region: 2024 VS 2031

Figure 21. Global ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Players in 2024

Figure 22. Global Top ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Revenue in 2024

Figure 24. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2020-2031)

Figure 26. United States ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2020-2031)

Figure 30. Germany ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Region (2020-2031)

Figure 38. China ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2020-2031)

Figure 46. Mexico ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Share by Country (2020-2031)

Figure 50. Turkey ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Pfizer Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 54. Nuvartis Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 55. Takeda Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 56. Betta Pharma Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 57. Shouyao Holding Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 58. Chugai Pharmaceutical Co Revenue Growth Rate in ALK Tyrosine Kinase Inhibitors (ALK-TKIs) Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions